Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Healthcare Industry News Why did Sellas Life Sciences file to register 19.69m shares, and how could this affect SLS stock performance in 2025? Sellas registers 19.69 M shares for resale after a warrant deal. Discover what it means for dilution, stock sentiment, and upcoming biotech catalysts. byPallavi MadhirajuOctober 14, 2025